Exabis Library
Welcome to the e-CCO Library!
DOP83: Proactive dosing is superior to clinically based dosing in terms of endoscopic healing in paediatric patients with Crohn's disease receiving maintenance infliximab: A randomized controlled trial
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP83: Proactive dosing is superior to clinically based dosing in terms of endoscopic healing in paediatric patients with Crohn’s disease receiving maintenance infliximab: A randomized controlled trial
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP84 Crohn’s disease modifies the DNA methylome of human adipose-stem cells, which is only partially re-established in remission
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP84: Colonic CD4+ T cell senescence is implicated in the progression of experimental colitis in aged mice
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP84: Crohn’s Disease modifies the DNA methylome of human adipose-stem cells, which is only partially re-established in remission
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP84: Crohn’s Disease modifies the DNA methylome of human adipose-stem cells, which is only partially re-established in remission
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP84: Early treatment responses within 14 days of intravenous vedolizumab induction therapy for Crohn’s Disease: Post hoc analysis of patient-reported outcomes from the VISIBLE 2 study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP84: IBD-related hospitalization and surgery rates in biologic-naïve patients with IBD treated with vedolizumab versus other biologics: Results from a long-term, prospective, observational study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP84: Nationwide incidence and prevalence of paediatric inflammatory bowel disease in Scotland 2015–2017 demonstrates the highest paediatric prevalence rate recorded worldwide
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP84: Risankizumab maintenance therapy results in sustained improvements in endoscopic outcomes in patients with moderate to severe Crohn’s Disease: Post-hoc analysis from the phase 3 study FORTIFY
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP85 The role of fibroblasts in the pathogenesis of Crohn’s disease-associated fistulas and in mesenchymal stem cell therapy
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP85: An anti-fibrotic role for eosinophils in a DSS colitis RAG-/- and an in vitro co-culture model
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP85: Corticosteroid-free efficacy and safety outcomes in patients receiving tofacitinib in the OCTAVE Sustain maintenance study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP85: Crohn's Disease Strictures Respond to Drug Treatment and Treat-to-Target Intense Combination Therapy is More Effective than Standard Anti-TNF Therapy. Two year results of the STRIDENT Randomised Controlled Trial.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP85: Crohn's Disease Strictures Respond to Drug Treatment and Treat-to-Target Intense Combination Therapy is More Effective than Standard Anti-TNF Therapy. Two year results of the STRIDENT Randomised Controlled Trial.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP85: Efficacy of risankizumab rescue therapy in patients with moderately to severely active Crohn’s Disease and inadequate response to risankizumab maintenance therapy
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP85: Rising depression and antidepressant use amongst inflammatory bowel disease patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP85: Rising depression and antidepressant use amongst Inflammatory Bowel Disease patients
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP86 An IFN-STAT1-MLKL axis drives programmed necrosis of Paneth cells in Crohn’s ileitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP86: Corticosteroid-sparing effects of ustekinumab therapy for Ulcerative Colitis through 3 years: UNIFI long-term extension
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM